The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Global statistics on alcohol, tobacco and illicit drug use: 2017 status report
Open accessAbstract
Aims: This review provides an up‐to‐date curated source of information on alcohol, tobacco and illicit drug use and their associated mortality and burden of disease. Limitations in the data are also discussed, including how these can be addressed in the future. Methods: Online data sources were identified through expert review. Data were obtained mainly from the World Health Organization, United Nations Office on Drugs and Crime and Institute for Health Metrics and Evaluation. Results: In 2015, the estimated prevalence among the adult population was 18.4% for heavy episodic alcohol use (in the past 30 days); 15.2% for daily tobacco smoking; and 3.8, 0.77, 0.37 and 0.35% for past‐year cannabis, amphetamine, opioid and cocaine use, respectively. European regions had the highest prevalence of heavy episodic alcohol use and daily tobacco use. The age‐standardized prevalence of alcohol dependence was 843.2 per 100 000 people; for cannabis, opioids, amphetamines and cocaine dependence it was 259.3, 220.4, 86.0 and 52.5 per 100 000 people, respectively. High‐income North America region had among the highest rates of cannabis, opioid and cocaine dependence. Attributable disability‐adjusted life‐years (DALYs) were highest for tobacco smoking (170.9 million DALYs), followed by alcohol (85.0 million) and illicit drugs (27.8 million). Substance‐attributable mortality rates were highest for tobacco smoking (110.7 deaths per 100 000 people), followed by alcohol and illicit drugs (33.0 and 6.9 deaths per 100 000 people, respectively). Attributable age‐standardized mortality rates and DALYs for alcohol and illicit drugs were highest in eastern Europe; attributable age‐standardized tobacco mortality rates and DALYs were highest in Oceania. Conclusions: In 2015 alcohol use and tobacco smoking use between them cost the human population more than a quarter of a billion disability‐adjusted life years, with illicit drugs costing further tens of millions. Europeans suffered proportionately more, but in absolute terms the mortality rate was greatest in low‐ and middle‐income countries with large populations and where the quality of data was more limited. Better standardized and rigorous methods for data collection, collation and reporting are needed to assess more accurately the geographical and temporal trends in substance use and its disease burden.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lim, S. S., Vos, T., Flaxman, A. D., Danaei, G., Shibuya, K., Adair-Rohani, H., AlMazroa, M. A., Amann, M., Anderson, H. R., Andrews, K. G., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61766-8 · Cited by 11,805
Self-citationWang, H., Naghavi, M., Allen, C., Barber, R. M., Bhutta, Z. A., Carter, A., Casey, D. C., Charlson, F. J., Chen, A. Z., Coates, M. M., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31012-1 · Cited by 6,596
Self-citationTransforming our world: the 2030 Agenda for Sustainable Development
(2022) · Sustainable Development Goals · doi:10.5040/9781509934058.0025 · Cited by 6,562
The Health consequences of smoking—50 years of progress : a report of the Surgeon General
Lushniak, B. D., Samet, J. M., Pechacek, T. F., Norman, L., & Taylor, P. A. (2014) · Cited by 4,990
Rehm, J., Mathers, C., Popova, S., Thavorncharoensap, M., Teerawattananon, Y., & Patra, J. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60746-7 · Cited by 3,870
Self-citationGeneral, U. S. S. (2014) · PsycEXTRA Dataset · doi:10.1037/e510072014-001 · Cited by 3,324
Ezzati, M., López, A. D., Rodgers, A., & Murray, C. J. L. (2004) · Cited by 3,319
Kassebaum, N. J., Arora, M., Barber, R. M., Bhutta, Z. A., Brown, J., Carter, A., Casey, D. C., Charlson, F. J., Coates, M. M., Coggeshall, M., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31460-x · Cited by 2,163
Self-citationReitsma, M. B., Fullman, N., Ng, M., Salama, J. S., Abajobir, A., Abate, K. H., Abbafati, C., Abera, S. F., Abraham, B., Abyu, G. Y., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30819-x · Cited by 2,028
Self-citationDegenhardt, L., Peacock, A., Colledge, S., Leung, J., Grebely, J., Vickerman, P., Stone, J., Cunningham, E. B., Trickey, A., Dumchev, K., et al. (2017) · The Lancet Global Health · doi:10.1016/s2214-109x(17)30375-3 · Cited by 1,429
Self-citation
Research works printed but not linked: 14
- 10.1097/COH.0000000000000041 · doi:10.1097/coh.0000000000000041
- European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), 2011, Responding to New Psychoactive Substances
- European Monitoring Centre for Drugs and Drug Addiction, 2017, European Drug Report 2017: Trends and Developments.
- 10.1016/S2215-0366(16)30405-9 · doi:10.1016/s2215-0366(16)30405-9
- World Health Organization (WHO), 2016, Global Information System on Alcohol and Health (GISAH)
- Institute for Health Metrics and Evaluation, 2016, GBD Results Tool
- American Psychiatric Association (APA), 2000, Diagnostic and Statistical Manual of Mental Disorders (DSM‐IV‐TR).
- World Health Organization (WHO), 1993, The ICD‐10 Classification of Mental and Behavioural Disorders—Diagnostic Criteria for Research
- Flaxman A. D., 2015, An Integrative Metaregression Framework for Descriptive Epidemiology
- Joint United Nations Programme on HIV/AIDS, 2014, 90‐90‐90: An Ambitious Treatment Target to Help End the AIDS Epidemic
- 10.1111/add.12185 · doi:10.1111/add.12185
- Institute for Health Metrics and Evaluation (IHME), 2015, A Protocol for the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD)
- United Nations Office on Drugs and Crime (UNODC), 2017, Methodology—World Drug Report 2017., 10.18356/c595e10f-en · DOI
- International Agency for Research on Cancer, 2008, IARC Handbooks of Cancer Prevention: Tobacco Control. Volume 12. Methods for Evaluating Tobacco Control Policies
Cited by
Feinstein, M. J., Hsue, P. Y., Benjamin, L. A., Bloomfield, G. S., Currier, J. S., Freiberg, M. S., Grinspoon, S. K., Levin, J., Longenecker, C. T., Post, W. S., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000695 · Cited by 658
Cannabis use and cannabis use disorder
Connor, J. P., Stjepanović, D., Le Foll, B., Hoch, E., Budney, A. J., & Hall, W. D. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00247-4 · Cited by 552
Epidemiological Features of Cardiovascular Disease in Asia
Zhao, D. (2021) · JACC: Asia · doi:10.1016/j.jacasi.2021.04.007 · Cited by 476
Hall, W., Stjepanović, D., Caulkins, J., Lynskey, M., Leung, J., Campbell, G., & Degenhardt, L. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31789-1 · Cited by 357
Self-citationThe COVID-19 pandemic and its impact on substance use: Implications for prevention and treatment
Ornell, F., Moura, H. F., Scherer, J. N., Pechansky, F., Kessler, F. H. P., & von Diemen, L. (2020) · Psychiatry Research · doi:10.1016/j.psychres.2020.113096 · Cited by 308
Alcohol consumption and metabolic syndrome: clinical and epidemiological impact on liver disease
Åberg, F., Byrne, C. D., Pirola, C. J., Männistö, V., & Sookoian, S. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2022.08.030 · Cited by 307
Assessing the public health impacts of legalizing recreational cannabis use: the US experience
Hall, W., & Lynskey, M. (2020) · World Psychiatry · doi:10.1002/wps.20735 · Cited by 296
Self-citationHunt, G. E., Malhi, G. S., Lai, H. M. X., & Cleary, M. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.01.141 · Cited by 289
Glantz, M. D., Bharat, C., Degenhardt, L., Sampson, N. A., Scott, K. M., Lim, C. C. W., Al-Hamzawi, A., Alonso, J., Andrade, L. H., Cardoso, G., et al. (2020) · Addictive Behaviors · doi:10.1016/j.addbeh.2019.106128 · Cited by 272
Self-citationDe Crescenzo, F., Ciabattini, M., D’Alò, G. L., De Giorgi, R., Del Giovane, C., Cassar, C., Janiri, L., Clark, N., Ostacher, M. J., & Cipriani, A. (2018) · PLOS Medicine · doi:10.1371/journal.pmed.1002715 · Cited by 274
Solmi, M., De Toffol, M., Kim, J. Y., Choi, M. J., Stubbs, B., Thompson, T., Firth, J., Miola, A., Croatto, G., Baggio, F., et al. (2023) · BMJ · doi:10.1136/bmj-2022-072348 · Cited by 271
Liu, S., Wang, B., Fan, S., Wang, Y., Zhan, Y., & Ye, D. (2022) · BMJ Open · doi:10.1136/bmjopen-2022-062183 · Cited by 265
The role of glucagon‐like peptide 1 (GLP‐1) in addictive disorders
Klausen, M. K., Thomsen, M., Wortwein, G., & Fink‐Jensen, A. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15677 · Cited by 259
Hatoum, A. S., Colbert, S. M. C., Johnson, E. C., Huggett, S. B., Deak, J. D., Pathak, G. A., Jennings, M. V., Paul, S. E., Karcher, N. R., Hansen, I., et al. (2023) · Nature Mental Health · doi:10.1038/s44220-023-00034-y · Cited by 241
He, H., Pan, Z., Wu, J., Hu, C., Bai, L., & Lyu, J. (2022) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntab265 · Cited by 153
Kiburi, S. K., Molebatsi, K., Ntlantsana, V., & Lynskey, M. T. (2021) · Substance Abuse · doi:10.1080/08897077.2021.1876200 · Cited by 115
“study 2016, showed cannabis dependence as the second common substance use disorder after alcohol.(2) The burden”
BackgroundAlcohol use disorders and ADHD.
Luderer, M., Ramos Quiroga, J. A., Faraone, S. V., Zhang-James, Y., & Reif, A. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.07.010 · Cited by 102
Pharmacotherapies for cannabis dependence
Nielsen, S., Gowing, L., Sabioni, P., & Le Foll, B. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008940.pub3 · Cited by 96
Self-citationCannabis Legalization and Detection of Tetrahydrocannabinol in Injured Drivers
Brubacher, J. R., Chan, H., Erdelyi, S., Staples, J. A., Asbridge, M., & Mann, R. E. (2022) · New England Journal of Medicine · doi:10.1056/nejmsa2109371 · Cited by 88
Risso, C., Boniface, S., Subbaraman, M. S., & Englund, A. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881120919970 · Cited by 87
“8 million cases of cannabis-use disorder where estimated (Degenhardt et al., 2013; Peacock et al., 2018).”
BackgroundInfluentialColyer-Patel, K., Kuhns, L., Weidema, A., Lesscher, H., & Cousijn, J. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105038 · Cited by 54
“Tobacco smoking carries the highest substance-attributable mortality rate and is estimated to be responsible for over seven million deaths worldwide each year (Peacock et al., 2018; WHO Factsheet, 2021).”
BackgroundGrummitt, L., Kelly, E., Barrett, E., Keyes, K., & Newton, N. (2021) · PLOS ONE · doi:10.1371/journal.pone.0252815 · Cited by 51
Bertholet, N., Godinho, A., & Cunningham, J. A. (2019) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.12.002 · Cited by 40
Narrative review on potential role of gut microbiota in certain substance addiction
Qin, C., Hu, J., Wan, Y., Cai, M., Wang, Z., Peng, Z., Liao, Y., Li, D., Yao, P., Liu, L., et al. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110093 · Cited by 32
Garnett, C., Kastaun, S., Brown, J., & Kotz, D. (2022) · Addictive Behaviors · doi:10.1016/j.addbeh.2021.107159 · Cited by 28
“Nevertheless, Germany is still one of the countries where the most alcohol is drunk (Peacock et al., 2018).”
BackgroundBickmore, T., Rubin, A., & Simon, S. (2020) · Proceedings of the 20th ACM International Conference on Intelligent Virtual Agents · doi:10.1145/3383652.3423869 · Cited by 29
A systematic review and meta-analysis of substance use among medical students in India
Sahu, A., Bhati, N., & Sarkar, S. (2022) · Indian Journal of Psychiatry · doi:10.4103/indianjpsychiatry.indianjpsychiatry_672_21 · Cited by 23
Current Interventions for People Living with HIV Who Use Alcohol: Why Gender Matters
Wechsberg, W. M., Browne, F. A., Bonner, C. P., Washio, Y., Howard, B. N., & van der Drift, I. (2021) · Current HIV/AIDS Reports · doi:10.1007/s11904-021-00558-x · Cited by 10
Constant, H. M. R. M., Ferigolo, M., Barros, H. M. T., & Moret-Tatay, C. (2021) · Psychiatry Research · doi:10.1016/j.psychres.2021.114068 · Cited by 9
Cognitive deficits in people with stimulant use disorders
Verdejo-Garcia, A., & Rubenis, A. J. (2020) · Cognition and Addiction · doi:10.1016/b978-0-12-815298-0.00011-3 · Cited by 9
Faller, J., Le, L. K.-D., Chatterton, M. L., Perez, J. K., Chiotelis, O., Tran, H. N. Q., Sultana, M., Hall, N., Lee, Y. Y., Chapman, C., et al. (2023) · BJPsych Open · doi:10.1192/bjo.2023.515 · Cited by 6
Metadata
- Authors
- Peacock, A., Leung, J., Larney, S., Colledge, S., Hickman, M., Rehm, J., Giovino, G. A., West, R., Hall, W., Griffiths, P., Ali, R., Gowing, L., Marsden, J., Ferrari, A. J., Grebely, J., Farrell, M., & Degenhardt, L.
- Venue
- Addiction
- Publisher
- Wiley
- Published
- 2018-06-04
- Volume
- 113
- Issue
- 10
- Pages
- 1905-1926
- ISSN
- 0965-2140 (ISSN-L)
- 1360-0443
- OpenAlex
- W2799505340
- Cited by
- 1,038
- References
- 32
- FWCI
- 66.99
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.